- €931.52m
- €899.22m
- €692.29m
- 91
- 47
- 92
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 401 | 408 | 571 | 674 | 692 |
Cost of Revenue | |||||
Gross Profit | 166 | 149 | 221 | 260 | 271 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 363 | 378 | 507 | 593 | 620 |
Operating Profit | 38.2 | 30.1 | 64.9 | 81 | 72.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38.6 | 27.9 | 66.4 | 79 | 71.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.8 | 22.5 | 49.1 | 59 | 50.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26 | 20.3 | 45.4 | 55.1 | 48.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26 | 20.3 | 45.4 | 55.1 | 48.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.321 | 0.251 | 0.57 | 0.691 | 0.603 |
Dividends per Share |